BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 22886243)

  • 1. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Llama single domain antibodies as a tool for molecular mimicry.
    Zarebski LM; Urrutia M; Goldbaum FA
    J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical improvement of rabbit derived single-domain antibodies by substitutions with amino acids conserved in camelid antibodies.
    Shinozaki N; Hashimoto R; Noda M; Uchiyama S
    J Biosci Bioeng; 2018 Jun; 125(6):654-661. PubMed ID: 29398547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid.
    Winichayakul S; Pernthaner A; Scott R; Vlaming R; Roberts N
    Biotechnol Appl Biochem; 2009 Jun; 53(Pt 2):111-22. PubMed ID: 18844608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of a naïve library of camelid single domain antibodies.
    Olichon A; de Marco A
    Methods Mol Biol; 2012; 911():65-78. PubMed ID: 22886246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
    Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody repertoire development in camelids.
    De Genst E; Saerens D; Muyldermans S; Conrath K
    Dev Comp Immunol; 2006; 30(1-2):187-98. PubMed ID: 16051357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris.
    Ryckaert S; Pardon E; Steyaert J; Callewaert N
    J Biotechnol; 2010 Jan; 145(2):93-8. PubMed ID: 19861136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalent display of single-domain antibodies.
    Zhang J; Mackenzie CR
    Methods Mol Biol; 2012; 911():445-56. PubMed ID: 22886268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
    Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
    J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
    Pain C; Dumont J; Dumoulin M
    Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-throughput sequencing.
    Miyazaki N; Kiyose N; Akazawa Y; Takashima M; Hagihara Y; Inoue N; Matsuda T; Ogawa R; Inoue S; Ito Y
    J Biochem; 2015 Sep; 158(3):205-15. PubMed ID: 25888581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the study of natural small molecular antibody].
    Zhu L; Zhang DP
    Yao Xue Xue Bao; 2012 Oct; 47(10):1281-6. PubMed ID: 23289139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of nanobodies for therapeutic applications.
    Van Bockstaele F; Holz JB; Revets H
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product.
    Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T
    Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nanobody against urease activity of Helicobacter pylori.
    Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
    Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody.
    Ahmadvand D; Rahbarizadeh F; Vishteh VK
    Hybridoma (Larchmt); 2008 Aug; 27(4):269-76. PubMed ID: 18707545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody.
    Rodríguez-Rodríguez ER; Ledezma-Candanoza LM; Contreras-Ferrat LG; Olamendi-Portugal T; Possani LD; Becerril B; Riaño-Umbarila L
    J Mol Biol; 2012 Oct; 423(3):337-50. PubMed ID: 22835504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.